| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 393 / 428 | 8th | Q4 |
| Cancer Research | 223 / 233 | 4th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Research on Prevention and Treatment
Cancer Research on Prevention and Treatment is Scopus-indexed (Q4, CiteScore 0.4), DOAJ. Published by CHINA RESEARCH ON PREVENTION AND TREATMENT.
Checked against the index lists dated .
ISSN 1000-8578Verify ISSN ↗
Publisher: CHINA RESEARCH ON PREVENTION AND TREATMENT
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Cancer Research on Prevention and Treatment indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q4, CiteScore 0.4.
What quartile is Cancer Research on Prevention and Treatment in Scopus?
Cancer Research on Prevention and Treatment is Q4 in Oncology (rank 393 of 428) and Q4 in Cancer Research (rank 223 of 233), by CiteScore 2025.
What is the impact factor of Cancer Research on Prevention and Treatment?
Cancer Research on Prevention and Treatment is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.4, quartile Q4, 8th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.121, quartile Q4, with an H-index of 7.
How much does it cost to publish in Cancer Research on Prevention and Treatment?
The publisher lists an article processing charge of about US$72 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Cancer Research on Prevention and Treatment and what is its ISSN?
Cancer Research on Prevention and Treatment is published by CHINA RESEARCH ON PREVENTION AND TREATMENT. Its ISSN is 1000-8578.
Is Cancer Research on Prevention and Treatment in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Cancer Research on Prevention and Treatment open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Cancer Research on Prevention and Treatment? — open metrics via OpenAlex
Cancer Research on Prevention and Treatment has an h-index of 5 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #402 of 424 Scopus journals in Oncology.
Cancer Research on Prevention and Treatment published 5 papers in 2020; its busiest recent year was 2011 with 273. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Cancer Research on Prevention and Treatment? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.